The
fluorescein derivative
phloxine B is a potent modulator of the
cystic fibrosis transmembrane conductance regulator (CFTR). Low micromolar concentrations of
phloxine B stimulate CFTR Cl(-) currents, whereas higher concentrations of the
drug inhibit CFTR. In this study, we investigated the mechanism of action of
phloxine B.
Phloxine B (1 microm) stimulated wild-type CFTR and the most common
cystic fibrosis mutation, DeltaF508, by increasing the open probability of phosphorylated CFTR Cl(-) channels. At each concentration of
ATP tested, the
drug slowed the rate of channel closure without altering the opening rate. Based on the effects of
fluorescein derivatives on transport
ATPases, these data suggest that
phloxine B might stimulate CFTR by binding to the
ATP-binding site of the second
nucleotide-binding domain (NBD2) to slow the dissociation of
ATP from NBD1. Channel block by
phloxine B (40 microm) was voltage-dependent, enhanced when external Cl(-) concentration was reduced and unaffected by
ATP (5 mm), suggesting that
phloxine B inhibits CFTR by occluding the pore. We conclude that
phloxine B interacts directly with CFTR at multiple sites to modulate channel activity. It or related agents might be of value in the development of new treatments for diseases caused by the malfunction of CFTR.